纽森签署 SB 41 管住药品福利管理人，加州出招压处方药价
2025年10月11日，美国加利福尼亚州州长 Gavin Newsom 在州府 Sacramento 签署第41号参议院法案（SB 41），把在药厂、保险公司与药店之间居中议价的药品福利管理人（PBM）纳入严格监管：禁止其从药价价差中获利，要求药厂回扣悉数让利给健康计划。州政府称，这是全美压低处方药价最有力的一步。
药品福利管理人是代表健康计划与保险公司同药厂谈价格、定报销目录的中间人，其获利方式长期受到质疑。按照新法与今年通过的一揽子预算配套法案，全州的药品福利管理人须向州管理式医疗保健部（Department of Managed Health Care）申领执照并接受监管。
新法的核心条款有三条：一是禁止「价差定价」，即药品福利管理人向健康计划收取的药价不得高于其付给药店的价格；二是药厂给予的回扣必须全额转交给健康计划，不得从中扣留；三是药品福利管理人向健康计划、保险公司等客户收费时，只能收取行政费用。
纽森说：「我欣然签署 SB 41，这部法案将降低所有加州人的医疗成本。」他表示，这部法律与2025年预算案中的一系列措施以及州营平价药品品牌 CalRx 一道，构成全国压低处方药成本最进取的努力，目的就是确保省下的钱回到付款方与消费者手中。
法案作者、代表 San Francisco 的州参议员 Scott Wiener 说：「加州正在站出来，替消费者对抗那些想在救命药上揩油的巨型企业。」他说，这部法律还将让社区药房获得公平竞争的机会，「任何家庭都不该被迫在救命药与餐桌上的食物之间作选择」。
Newsom Signs SB 41 to Rein In Pharmacy Benefit Managers and Lower Prescription Drug Costs
On October 11, 2025, California Governor Gavin Newsom signed Senate Bill 41 (SB 41) in Sacramento, bringing pharmacy benefit managers (PBMs) — the middlemen that negotiate drug prices among manufacturers, insurers and pharmacies — under strict state regulation: they will be barred from profiting from drug price spreads, and manufacturer rebates must be passed through in full to health plans. The state called it the most aggressive effort in the country to lower prescription drug costs.
Pharmacy benefit managers negotiate prices and set coverage formularies on behalf of health plans and insurers, and the way they make money has long been questioned. Under the new law and a budget trailer bill enacted this year, every PBM operating in California must be licensed and regulated by the state Department of Managed Health Care.
The law has three core provisions: it prohibits spread pricing, meaning a PBM may not charge a health plan more for a drug than it pays the pharmacy; manufacturer rebates must be passed through in full to health plans and may not be withheld; and PBMs may charge health plan and insurer clients only administrative fees.
"I am pleased to sign SB 41, a bill that will lower health care costs for all Californians," Newsom said. He said the law, together with efforts in the 2025 state budget and the state's CalRx affordable-drug brand, amounts to the most aggressive effort in the country to lower prescription drug costs, ensuring the savings are passed on to payers and consumers.
The bill's author, state Senator Scott Wiener of San Francisco, said: "California is standing up for consumers against giant mega corporations trying to rip them off on essential medications." He said the law also gives neighborhood pharmacies a fair shot, adding that no family should be forced to choose between lifesaving medications and putting food on the table.
来源：加州州长办公室
发布：GSM·美国（发布链接）
图片来源：图：药房工作人员清点处方药胶囊（资料照片）。美国空军第52医疗大队官方发布，公共领域，经 Wikimedia Commons。 / Photo: A pharmacy worker counts prescription capsules (file photo). By the U.S. Air Force 52nd Medical Group, public domain, via Wikimedia Commons.
GSM Global · 本篇英文版 English edition of this story
